Insider Trading Summary for Taysha Gene Therapies, Inc. (TSHA): Year

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
06-Feb-24 4:42 PM View:	02-Feb-24 Payment of Exercise ($1.94K)	Alam Kamran Chief Financial Officer		Taysha Gene Therapies, Inc. - TSHA	195% 284.81K to 840.94K	0	0	--	--	Show Txns Hide Txns

16-Aug-23 8:51 PM View:	16-Aug-23 Private Purchase $100.00K	Donenberg Philip B Director		Taysha Gene Therapies, Inc. - TSHA	3704% 3.0K to 114.11K	0	0	--	--	Show Txns Hide Txns

04-Jan-24 4:42 PM View:	02-Jan-24 Grant 0	Nagendran Sukumar President and Head of R&D Director		Taysha Gene Therapies, Inc. - TSHA	2972% 29.23K to 897.84K	0	0	--	--	Show Txns Hide Txns

04-Jan-24 4:41 PM View:	02-Jan-24 Grant 0	Nolan Sean P. Chief Executive Officer Director		Taysha Gene Therapies, Inc. - TSHA	149% 1.09M to 2.72M	0	0	--	--	Show Txns Hide Txns

14-Jul-23 4:00 PM View:	13-Jul-23 Sale ($3.74K)	Session R.A. II 10% Owner		Taysha Gene Therapies, Inc. - TSHA	(6%) 9.7M to 9.15M	0	0	--	--	Show Txns Hide Txns

16-Aug-23 8:53 PM View:	16-Aug-23 Purchase $350.00K	Stalfort Sean Director		Taysha Gene Therapies, Inc. - TSHA	75% 1.11M to 1.93M	0	0	--	--	Show Txns Hide Txns

20-Nov-23 7:35 AM View:	17-Nov-23 Private Purchase $163.00K	Manning Paul B 10% Owner		Taysha Gene Therapies, Inc. - TSHA	238% 6.95M to 23.52M	0	0	--	--	Show Txns Hide Txns

Buy:	0	--
Sell:	0	--